CARVEDILOL

CARVEDILOL was reported 136143 times

CARVEDILOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEPHROGENIC ANAEMIA 926 0.1997
1 BRASH SYNDROME 279 0.1987
2 HYPERPARATHYROIDISM SECONDARY 496 0.1978
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 210 0.1977
4 ISCHAEMIC CARDIOMYOPATHY 381 0.1241
5 CARDIOACTIVE DRUG LEVEL INCREASED 154 0.1171
6 DYSPNOEA PAROXYSMAL NOCTURNAL 81 0.1111
7 REBOUND ACID HYPERSECRETION 307 0.1014
8 END STAGE RENAL DISEASE 1759 0.0963
9 IMPLANTABLE DEFIBRILLATOR INSERTION 127 0.0959
10 LEFT ATRIAL DILATATION 115 0.0901
11 ORTHOPNOEA 271 0.0850
12 ESSENTIAL HYPERTENSION 152 0.0830
13 HAEMORRHAGIC ANAEMIA 355 0.0807
14 CARDIAC FAILURE CHRONIC 338 0.0792
15 CAROTID ARTERIOSCLEROSIS 80 0.0775
16 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 103 0.0733
17 PRODUCT MONITORING ERROR 99 0.0685
18 RENAL ARTERY STENOSIS 93 0.0674
19 LEFT VENTRICULAR HYPERTROPHY 286 0.0668
20 ECHOCARDIOGRAM ABNORMAL 93 0.0664
21 VENTRICULAR HYPOKINESIA 213 0.0663
22 CONGESTIVE CARDIOMYOPATHY 276 0.0662
23 DIASTOLIC DYSFUNCTION 201 0.0650
24 EJECTION FRACTION DECREASED 959 0.0616
25 BUNDLE BRANCH BLOCK LEFT 261 0.0615
26 MITRAL VALVE INCOMPETENCE 675 0.0596
27 AORTIC VALVE INCOMPETENCE 237 0.0556
28 CARDIAC FAILURE CONGESTIVE 4463 0.0555
29 CHRONIC KIDNEY DISEASE 4071 0.0535
30 CARDIOMYOPATHY 790 0.0534
31 TRICUSPID VALVE INCOMPETENCE 410 0.0516
32 DILATATION VENTRICULAR 107 0.0509
33 LEFT VENTRICULAR DYSFUNCTION 337 0.0503
34 BRAIN NATRIURETIC PEPTIDE INCREASED 155 0.0502
35 CARDIOMEGALY 615 0.0499
36 THERAPEUTIC AGENT TOXICITY 166 0.0497
37 MITRAL VALVE DISEASE 87 0.0491
38 AORTIC ARTERIOSCLEROSIS 124 0.0481
39 RENAL FAILURE CHRONIC 357 0.0464
40 VENTRICULAR DYSFUNCTION 118 0.0454
41 HYPERTENSIVE HEART DISEASE 85 0.0454
42 ATRIOVENTRICULAR BLOCK FIRST DEGREE 193 0.0445
43 BLOOD LOSS ANAEMIA 100 0.0441
44 CAROTID ARTERY STENOSIS 150 0.0429
45 CARDIAC FAILURE ACUTE 277 0.0415
46 LEFT VENTRICULAR FAILURE 142 0.0412
47 LOWER GASTROINTESTINAL HAEMORRHAGE 304 0.0411
48 BLOOD POTASSIUM INCREASED 664 0.0409
49 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 100 0.0404
50 CORONARY ARTERIAL STENT INSERTION 202 0.0398
51 CORONARY ARTERY DISEASE 1191 0.0393
52 MULTIPLE INJURIES 243 0.0386
53 RENAL INJURY 1131 0.0380
54 VENTRICULAR TACHYCARDIA 618 0.0374
55 RALES 216 0.0372
56 DIVERTICULUM INTESTINAL HAEMORRHAGIC 83 0.0369
57 VENTRICULAR ARRHYTHMIA 135 0.0369
58 HYPERKALAEMIA 1274 0.0363
59 ATRIOVENTRICULAR BLOCK 280 0.0362
60 ANGINA UNSTABLE 234 0.0360
61 PERIPHERAL VASCULAR DISORDER 185 0.0359
62 SUSPECTED SUICIDE 168 0.0358
63 HYPOVOLAEMIA 208 0.0355
64 UPPER GASTROINTESTINAL HAEMORRHAGE 595 0.0353
65 ATRIAL FLUTTER 282 0.0353
66 THROAT CLEARING 131 0.0349
67 CARDIAC FAILURE 2801 0.0349
68 AORTIC STENOSIS 121 0.0347
69 ACUTE MYOCARDIAL INFARCTION 1010 0.0342
70 CARDIOGENIC SHOCK 486 0.0338
71 ECONOMIC PROBLEM 512 0.0338
72 BLOOD CHLORIDE DECREASED 87 0.0337
73 BLOOD PRESSURE INADEQUATELY CONTROLLED 202 0.0335
74 INTRACARDIAC THROMBUS 103 0.0335
75 SINUS BRADYCARDIA 323 0.0334
76 CORONARY ARTERY STENOSIS 167 0.0332
77 CORONARY ARTERY OCCLUSION 452 0.0329
78 DIVERTICULUM INTESTINAL 144 0.0329
79 METABOLIC ENCEPHALOPATHY 98 0.0326
80 DIABETIC NEUROPATHY 161 0.0325
81 BREATH SOUNDS ABNORMAL 160 0.0324
82 BRADYCARDIA 1715 0.0323
83 ARTERIOSCLEROSIS 304 0.0323
84 CARDIAC PACEMAKER INSERTION 192 0.0322
85 AZOTAEMIA 128 0.0320
86 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 130 0.0318
87 RENAL FAILURE 4214 0.0317
88 CORONARY ARTERY BYPASS 180 0.0313
89 BLOOD UREA INCREASED 523 0.0312
90 VENTRICULAR EXTRASYSTOLES 317 0.0305
91 ARTERIOSCLEROSIS CORONARY ARTERY 202 0.0305
92 CARDIAC DYSFUNCTION 113 0.0303
93 HYPERLIPIDAEMIA 360 0.0301
94 DYSPNOEA AT REST 87 0.0300
95 VARICES OESOPHAGEAL 90 0.0297
96 CARDIAC VALVE DISEASE 170 0.0297
97 CARDIAC MURMUR 257 0.0297
98 DIVERTICULUM 211 0.0297
99 BLOOD POTASSIUM ABNORMAL 79 0.0296
100 BENIGN PROSTATIC HYPERPLASIA 153 0.0296
101 ACUTE KIDNEY INJURY 4527 0.0296
102 GASTROINTESTINAL HAEMORRHAGE 2461 0.0294
103 SUPRAVENTRICULAR EXTRASYSTOLES 99 0.0293
104 ELECTROCARDIOGRAM ABNORMAL 227 0.0289
105 NEPHROPATHY 269 0.0288
106 NEPHROGENIC SYSTEMIC FIBROSIS 87 0.0288
107 DIZZINESS POSTURAL 279 0.0287
108 HYPOTENSION 5755 0.0287
109 LARGE INTESTINE POLYP 198 0.0286
110 INTERNATIONAL NORMALISED RATIO INCREASED 813 0.0285
111 GLOMERULAR FILTRATION RATE DECREASED 350 0.0285
112 PULMONARY OEDEMA 1269 0.0283
113 HYPERVOLAEMIA 139 0.0281
114 CATHETERISATION CARDIAC 124 0.0279
115 MYOCARDIAL ISCHAEMIA 306 0.0269
116 BLOOD PRESSURE SYSTOLIC DECREASED 122 0.0268
117 ATELECTASIS 259 0.0268
118 PULMONARY HYPERTENSION 558 0.0268
119 IRON DEFICIENCY ANAEMIA 247 0.0267
120 DYSLIPIDAEMIA 135 0.0266
121 PULSELESS ELECTRICAL ACTIVITY 111 0.0265
122 ARTERIAL OCCLUSIVE DISEASE 208 0.0264
123 INTERNATIONAL NORMALISED RATIO DECREASED 106 0.0262
124 GOUT 468 0.0261
125 ATRIAL FIBRILLATION 2521 0.0259
126 BLOOD PRESSURE DECREASED 1719 0.0258
127 FLUID OVERLOAD 374 0.0257
128 RENAL FAILURE ACUTE 1090 0.0257
129 VENTRICULAR FIBRILLATION 283 0.0255
130 RENAL CYST 201 0.0253
131 FLUID RETENTION 1276 0.0251
132 HEART RATE DECREASED 860 0.0245
133 RENAL TUBULAR NECROSIS 240 0.0244
134 PULSE ABSENT 116 0.0244
135 ATRIOVENTRICULAR BLOCK COMPLETE 163 0.0243
136 COAGULOPATHY 404 0.0242
137 AORTIC ANEURYSM 184 0.0242
138 ORTHOSTATIC HYPOTENSION 417 0.0239
139 ANGINA PECTORIS 684 0.0238
140 CONCOMITANT DISEASE AGGRAVATED 147 0.0238
141 STENT PLACEMENT 192 0.0238
142 ACUTE RESPIRATORY FAILURE 458 0.0238
143 SPINAL OSTEOARTHRITIS 206 0.0234
144 BLOOD CREATININE INCREASED 1529 0.0234
145 PROTHROMBIN TIME PROLONGED 140 0.0234
146 DYSPNOEA EXERTIONAL 875 0.0232
147 HYPERURICAEMIA 95 0.0231
148 BUNDLE BRANCH BLOCK RIGHT 104 0.0226
149 EXERCISE TOLERANCE DECREASED 130 0.0226
150 HEART RATE IRREGULAR 506 0.0224
151 PULMONARY CONGESTION 294 0.0223
152 BLOOD CREATININE ABNORMAL 77 0.0222
153 INTERNAL HAEMORRHAGE 254 0.0222
154 WEIGHT FLUCTUATION 232 0.0222
155 FAILURE TO THRIVE 115 0.0221
156 HAEMORRHOIDAL HAEMORRHAGE 108 0.0221
157 TUBULOINTERSTITIAL NEPHRITIS 412 0.0220
158 PERICARDIAL EFFUSION 507 0.0219
159 GASTRITIS EROSIVE 102 0.0219
160 PRESYNCOPE 531 0.0218
161 SPINAL STENOSIS 90 0.0218
162 ACUTE PULMONARY OEDEMA 122 0.0217
163 DIALYSIS 306 0.0215
164 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 109 0.0215
165 BLOOD MAGNESIUM DECREASED 185 0.0214
166 URINE OUTPUT DECREASED 187 0.0214
167 HYPERTENSIVE CRISIS 236 0.0212
168 MYOCARDIAL INFARCTION 3685 0.0211
169 HAEMATOCRIT DECREASED 417 0.0210
170 TROPONIN INCREASED 157 0.0206
171 RENAL IMPAIRMENT 1723 0.0205
172 MENTAL STATUS CHANGES 568 0.0204
173 BLOOD IRON DECREASED 242 0.0204
174 BLOOD PRESSURE ABNORMAL 405 0.0203
175 SHOCK 463 0.0201
176 PROSTATOMEGALY 79 0.0201
177 OEDEMA PERIPHERAL 2445 0.0200
178 SUBDURAL HAEMATOMA 287 0.0200
179 GASTRIC ULCER HAEMORRHAGE 111 0.0200
180 CARDIAC FLUTTER 129 0.0199
181 CARDIAC DISORDER 1866 0.0199
182 BLOOD URIC ACID INCREASED 114 0.0197
183 INFARCTION 135 0.0197
184 ANHEDONIA 515 0.0196
185 SLEEP APNOEA SYNDROME 374 0.0196
186 BLOOD POTASSIUM DECREASED 589 0.0196
187 RESPIRATORY ACIDOSIS 77 0.0196
188 HAEMORRHAGIC STROKE 152 0.0194
189 SUPRAVENTRICULAR TACHYCARDIA 186 0.0194
190 CARDIAC TAMPONADE 92 0.0193
191 LUNG INFILTRATION 171 0.0193
192 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 171 0.0193
193 CARDIAC OPERATION 166 0.0193
194 ARRHYTHMIA 911 0.0192
195 HAIR DISORDER 158 0.0192
196 DECUBITUS ULCER 154 0.0189
197 PLEURAL EFFUSION 1148 0.0188
198 SYNCOPE 1882 0.0188
199 INCREASED TENDENCY TO BRUISE 172 0.0187
200 HEART RATE ABNORMAL 104 0.0186
201 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 967 0.0185
202 OLIGURIA 115 0.0185
203 BODY HEIGHT DECREASED 198 0.0185
204 HYPOGLYCAEMIA 892 0.0184
205 POLYP 120 0.0183
206 BLOOD SODIUM DECREASED 344 0.0182
207 HOSPICE CARE 180 0.0182
208 RENAL DISORDER 849 0.0182
209 RECTAL HAEMORRHAGE 781 0.0182
210 BLOOD PRESSURE FLUCTUATION 436 0.0181
211 UNRESPONSIVE TO STIMULI 468 0.0181
212 DECREASED ACTIVITY 195 0.0181
213 ISCHAEMIA 83 0.0180
214 SHOCK HAEMORRHAGIC 146 0.0179
215 HAEMATURIA 612 0.0179
216 FULL BLOOD COUNT DECREASED 360 0.0178
217 BLOOD CREATINE INCREASED 79 0.0178
218 ECCHYMOSIS 122 0.0178
219 KIDNEY TRANSPLANT REJECTION 85 0.0177
220 MELAENA 389 0.0177
221 FLANK PAIN 165 0.0176
222 GANGRENE 106 0.0176
223 ANGIOPATHY 98 0.0175
224 CARDIO-RESPIRATORY ARREST 731 0.0175
225 BLOOD PRESSURE INCREASED 2654 0.0173
226 HAIR COLOUR CHANGES 215 0.0173
227 HYPOVOLAEMIC SHOCK 82 0.0171
228 HAEMORRHOIDS 333 0.0171
229 CARDIAC ARREST 1402 0.0170
230 HAEMOGLOBIN DECREASED 1738 0.0169
231 HIATUS HERNIA 219 0.0169
232 MALNUTRITION 189 0.0169
233 PERIPHERAL COLDNESS 231 0.0168
234 EXTRASYSTOLES 117 0.0167
235 DEHYDRATION 2232 0.0167
236 TORSADE DE POINTES 131 0.0167
237 ANEURYSM 83 0.0167
238 ANAEMIA 3163 0.0166
239 HAEMODIALYSIS 139 0.0165
240 ACUTE CORONARY SYNDROME 137 0.0165
241 ASCITES 486 0.0165
242 CHEST PAIN 3053 0.0165
243 IMPAIRED GASTRIC EMPTYING 224 0.0164
244 HYPERTENSION 3467 0.0164
245 EPISTAXIS 1222 0.0163
246 RED BLOOD CELL COUNT DECREASED 465 0.0162
247 NOCTURIA 195 0.0160
248 GASTRITIS 420 0.0159
249 DIABETES MELLITUS INADEQUATE CONTROL 282 0.0159
250 OBESITY 253 0.0159
251 PSYCHOLOGICAL TRAUMA 137 0.0159
252 BLOOD PRESSURE DIASTOLIC DECREASED 117 0.0158
253 HYPOXIA 555 0.0157
254 SUBARACHNOID HAEMORRHAGE 160 0.0157
255 POLYURIA 128 0.0156
256 HAEMORRHAGE INTRACRANIAL 232 0.0155
257 OEDEMA 841 0.0155
258 COMPLETED SUICIDE 1292 0.0155
259 BLOOD URINE PRESENT 293 0.0154
260 MOUTH HAEMORRHAGE 113 0.0154
261 DUODENAL ULCER 108 0.0153
262 GLYCOSYLATED HAEMOGLOBIN INCREASED 386 0.0153
263 HAEMOPTYSIS 424 0.0152
264 HAEMATOMA 393 0.0152
265 ISCHAEMIC STROKE 269 0.0151
266 SQUAMOUS CELL CARCINOMA OF SKIN 91 0.0151
267 DYSPNOEA 8485 0.0150
268 MULTI-ORGAN FAILURE 259 0.0150
269 RESPIRATORY FAILURE 1088 0.0149
270 MUSCULOSKELETAL CHEST PAIN 230 0.0148
271 ELECTROLYTE IMBALANCE 172 0.0148
272 CACHEXIA 76 0.0148
273 PERITONITIS BACTERIAL 149 0.0148
274 ASTHENIA 5512 0.0146
275 BLOOD GLUCOSE DECREASED 701 0.0146
276 SERUM FERRITIN INCREASED 77 0.0146
277 HAIR TEXTURE ABNORMAL 195 0.0146
278 HEPATIC ENCEPHALOPATHY 135 0.0145
279 VITAMIN D DEFICIENCY 141 0.0144
280 BLOOD GLUCOSE FLUCTUATION 158 0.0144
281 DRUG INTERACTION 2284 0.0144
282 SKIN ULCER 372 0.0144
283 GLUCOSE TOLERANCE IMPAIRED 85 0.0144
284 BLOOD CALCIUM DECREASED 161 0.0143
285 GENERALISED OEDEMA 177 0.0143
286 CHOLECYSTITIS ACUTE 81 0.0143
287 FEAR 384 0.0143
288 INTERVERTEBRAL DISC DEGENERATION 132 0.0143
289 HYPOMAGNESAEMIA 198 0.0142
290 DIZZINESS 7052 0.0141
291 TRANSIENT ISCHAEMIC ATTACK 477 0.0141
292 PERIPHERAL SWELLING 2177 0.0141
293 PRE-EXISTING CONDITION IMPROVED 88 0.0141
294 DIABETES MELLITUS 1071 0.0140
295 ULCER HAEMORRHAGE 95 0.0140
296 HYPERGLYCAEMIA 511 0.0140
297 BLOOD PRESSURE SYSTOLIC INCREASED 273 0.0140
298 HYPOKALAEMIA 646 0.0140
299 HYPONATRAEMIA 786 0.0139
300 METABOLIC ACIDOSIS 446 0.0139
301 TRANSFUSION 146 0.0139
302 PULMONARY ALVEOLAR HAEMORRHAGE 78 0.0139
303 BLOOD ALBUMIN DECREASED 110 0.0139
304 SLUGGISHNESS 141 0.0138
305 EYE HAEMORRHAGE 184 0.0138
306 CONTUSION 1327 0.0138
307 SEASONAL ALLERGY 195 0.0138
308 GASTROOESOPHAGEAL REFLUX DISEASE 1109 0.0138
309 HYDRONEPHROSIS 103 0.0137
310 FAECES DISCOLOURED 298 0.0137
311 RIGHT VENTRICULAR FAILURE 96 0.0137
312 MADAROSIS 159 0.0137
313 POST PROCEDURAL HAEMORRHAGE 159 0.0136
314 POLLAKIURIA 569 0.0136
315 EMPHYSEMA 137 0.0136
316 LOW DENSITY LIPOPROTEIN INCREASED 105 0.0136
317 FALL 4508 0.0135
318 RIB FRACTURE 278 0.0135
319 CLOSTRIDIUM DIFFICILE COLITIS 143 0.0135
320 SCOLIOSIS 83 0.0134
321 PRESCRIBED UNDERDOSE 267 0.0134
322 PRODUCT ADMINISTRATION INTERRUPTED 105 0.0134
323 CELLULITIS 673 0.0133
324 BLOOD COUNT ABNORMAL 202 0.0133
325 STRESS CARDIOMYOPATHY 77 0.0132
326 URINARY TRACT INFECTION 2249 0.0132
327 REFUSAL OF TREATMENT BY PATIENT 86 0.0132
328 BACTERAEMIA 156 0.0131
329 DYSURIA 482 0.0131
330 MUSCLE STRAIN 113 0.0130
331 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 134 0.0130
332 CEREBROVASCULAR ACCIDENT 2204 0.0130
333 ROTATOR CUFF SYNDROME 167 0.0130
334 GROIN PAIN 113 0.0129
335 BRONCHITIS 952 0.0128
336 HYPERCHOLESTEROLAEMIA 124 0.0128
337 PNEUMONIA 4152 0.0128
338 ACIDOSIS 98 0.0128
339 BOWEL MOVEMENT IRREGULARITY 98 0.0128
340 ANAL INCONTINENCE 115 0.0128
341 HAEMOGLOBIN ABNORMAL 82 0.0127
342 GINGIVAL BLEEDING 174 0.0127
343 DECREASED APPETITE 2959 0.0127
344 HAEMATEMESIS 321 0.0127
345 WEIGHT DECREASED 3529 0.0126
346 PNEUMONIA BACTERIAL 116 0.0126
347 ABASIA 312 0.0126
348 RESPIRATION ABNORMAL 87 0.0126
349 PRODUCTIVE COUGH 602 0.0126
350 SKIN LACERATION 137 0.0126
351 SPINAL COMPRESSION FRACTURE 104 0.0126
352 SUDDEN DEATH 133 0.0126
353 HEPATIC CIRRHOSIS 236 0.0125
354 LEUKOCYTOSIS 227 0.0125
355 HYPOPHAGIA 320 0.0125
356 PALLOR 340 0.0125
357 DYSSTASIA 364 0.0125
358 CEREBRAL INFARCTION 302 0.0123
359 HEAD INJURY 391 0.0123
360 HEPATIC STEATOSIS 230 0.0123
361 BLOOD TRIGLYCERIDES INCREASED 218 0.0123
362 TYPE 2 DIABETES MELLITUS 413 0.0123
363 OSTEOMYELITIS 222 0.0122
364 UROSEPSIS 113 0.0122
365 LETHARGY 704 0.0122
366 BLOOD GLUCOSE INCREASED 2300 0.0122
367 CEREBRAL HAEMORRHAGE 436 0.0122
368 RESPIRATORY DISTRESS 335 0.0121
369 GASTRIC ULCER 230 0.0121
370 LOSS OF CONSCIOUSNESS 1550 0.0121
371 CHOKING 235 0.0120
372 LOCALISED INFECTION 291 0.0120
373 HEPATOMEGALY 118 0.0120
374 OSTEOARTHRITIS 509 0.0120
375 PROTEINURIA 228 0.0120
376 FLUSHING 1218 0.0120
377 LIMB INJURY 325 0.0120
378 COUGH 3337 0.0119
379 KIDNEY INFECTION 233 0.0119
380 HYPOKINESIA 172 0.0118
381 VITAMIN D DECREASED 101 0.0118
382 NERVE COMPRESSION 109 0.0118
383 LACERATION 111 0.0118
384 DIVERTICULITIS 327 0.0118
385 HYPERSOMNIA 338 0.0118
386 ORAL PAIN 264 0.0118
387 HAEMATOCHEZIA 649 0.0117
388 SEPSIS 1310 0.0117
389 ABNORMAL LOSS OF WEIGHT 80 0.0117
390 LYMPHOEDEMA 81 0.0117
391 RESTLESS LEGS SYNDROME 213 0.0117
392 PLATELET COUNT DECREASED 1246 0.0117
393 PULMONARY MASS 174 0.0117
394 URINARY INCONTINENCE 346 0.0117
395 CHOLECYSTITIS 139 0.0117
396 FATIGUE 9046 0.0116
397 ASPIRATION 127 0.0116
398 MYOPATHY 100 0.0116
399 CATARACT 689 0.0116
400 CONSTIPATION 2522 0.0116
401 FLATULENCE 655 0.0115
402 SINUS TACHYCARDIA 164 0.0115
403 MUSCULAR WEAKNESS 1311 0.0115
404 HYPOTHYROIDISM 368 0.0115
405 EXOSTOSIS 105 0.0115
406 CHOLELITHIASIS 377 0.0115
407 ANOREXIA 148 0.0115
408 PULMONARY THROMBOSIS 125 0.0115
409 HIP FRACTURE 366 0.0114
410 HYPOTHERMIA 115 0.0113
411 MULTIPLE ALLERGIES 89 0.0113
412 RHABDOMYOLYSIS 473 0.0113
413 HEART RATE INCREASED 1120 0.0113
414 BLOOD CALCIUM INCREASED 99 0.0113
415 GAIT INABILITY 376 0.0112
416 GASTROENTERITIS 164 0.0112
417 BLOOD DISORDER 90 0.0112
418 DIARRHOEA 7248 0.0112
419 THROMBOSIS 903 0.0112
420 OSTEOPENIA 170 0.0112
421 TASTE DISORDER 227 0.0112
422 SPLENOMEGALY 131 0.0112
423 PROSTATIC SPECIFIC ANTIGEN INCREASED 154 0.0112
424 CHEST DISCOMFORT 1142 0.0111
425 SEPTIC SHOCK 485 0.0111
426 RESPIRATORY TRACT CONGESTION 177 0.0111
427 BALANCE DISORDER 959 0.0111
428 OESOPHAGITIS 121 0.0111
429 BACK PAIN 2571 0.0111
430 DYSPHONIA 647 0.0111
431 HYPOALBUMINAEMIA 86 0.0110
432 ANURIA 95 0.0110
433 ANKLE FRACTURE 170 0.0110
434 DISORIENTATION 435 0.0110
435 TOOTH FRACTURE 121 0.0110
436 QUALITY OF LIFE DECREASED 147 0.0109
437 OXYGEN SATURATION DECREASED 615 0.0109
438 HEMIPARESIS 185 0.0109
439 APNOEA 85 0.0109
440 TREATMENT NONCOMPLIANCE 597 0.0109
441 DYSARTHRIA 410 0.0109
442 ELECTROCARDIOGRAM QT PROLONGED 390 0.0108
443 SPINAL FRACTURE 217 0.0108
444 MUSCLE ATROPHY 137 0.0108
445 CYANOSIS 170 0.0108
446 GAIT DISTURBANCE 2068 0.0108
447 MACULAR DEGENERATION 129 0.0108
448 PELVIC FRACTURE 84 0.0108
449 COLD SWEAT 190 0.0108
450 BACK DISORDER 175 0.0108
451 HAEMODYNAMIC INSTABILITY 82 0.0108
452 PULMONARY HAEMORRHAGE 84 0.0107
453 HERNIA 207 0.0107
454 THIRST 191 0.0107
455 MUSCULOSKELETAL PAIN 556 0.0106
456 BLOOD GLUCOSE ABNORMAL 196 0.0106
457 INCONTINENCE 112 0.0106
458 CLOSTRIDIUM DIFFICILE INFECTION 231 0.0106
459 LABORATORY TEST ABNORMAL 312 0.0106
460 UPPER-AIRWAY COUGH SYNDROME 87 0.0105
461 SCIATICA 168 0.0105
462 ABDOMINAL DISTENSION 1100 0.0105
463 PRODUCT PRESCRIBING ERROR 250 0.0105
464 UPPER LIMB FRACTURE 209 0.0105
465 CYSTITIS 334 0.0105
466 TRANSPLANT REJECTION 84 0.0105
467 PALPITATIONS 1228 0.0105
468 STAPHYLOCOCCAL INFECTION 345 0.0104
469 SPINAL DISORDER 99 0.0104
470 SINUS CONGESTION 141 0.0104
471 CARDIOTOXICITY 93 0.0104
472 ENCEPHALOPATHY 256 0.0104
473 PNEUMONIA ASPIRATION 260 0.0104
474 EATING DISORDER 221 0.0104
475 NECK PAIN 578 0.0103
476 GASTRIC HAEMORRHAGE 119 0.0103
477 CONTRAINDICATED PRODUCT ADMINISTERED 313 0.0103
478 SMALL INTESTINAL OBSTRUCTION 127 0.0103
479 LIGAMENT SPRAIN 102 0.0103
480 THYROID DISORDER 159 0.0103
481 POST PROCEDURAL COMPLICATION 198 0.0103
482 GALLBLADDER DISORDER 184 0.0103
483 AGEUSIA 257 0.0103
484 BLINDNESS UNILATERAL 145 0.0103
485 TENDERNESS 107 0.0103
486 URINARY RETENTION 342 0.0102
487 SKIN DISCOLOURATION 471 0.0102
488 DYSPEPSIA 1008 0.0102
489 DRY THROAT 104 0.0102
490 EAR DISCOMFORT 105 0.0102
491 RETCHING 218 0.0102
492 BLOOD CHOLESTEROL INCREASED 474 0.0102
493 LIMB DISCOMFORT 314 0.0101
494 PAIN IN EXTREMITY 2988 0.0101
495 RESPIRATORY ARREST 279 0.0101
496 SINUS DISORDER 200 0.0101
497 DEMENTIA 282 0.0101
498 UNEVALUABLE EVENT 763 0.0101
499 CONFUSIONAL STATE 1626 0.0101
500 SWELLING 941 0.0100
501 PYELONEPHRITIS 87 0.0100
502 WEIGHT INCREASED 2244 0.0100
503 DRY MOUTH 812 0.0100
504 VITREOUS FLOATERS 98 0.0100
505 EYE PAIN 561 0.0099
506 INITIAL INSOMNIA 102 0.0099
507 CARPAL TUNNEL SYNDROME 139 0.0099
508 WHITE BLOOD CELL COUNT INCREASED 380 0.0099
509 FEELING HOT 607 0.0099
510 PLASMA CELL MYELOMA 386 0.0099
511 DRUG PRESCRIBING ERROR 190 0.0099
512 HYPOCALCAEMIA 187 0.0099
513 MUSCLE DISORDER 80 0.0099
514 CARDIOVASCULAR DISORDER 250 0.0098
515 INJURY 692 0.0098
516 FEELING COLD 274 0.0098
517 MICTURITION URGENCY 112 0.0098
518 NERVE INJURY 109 0.0098
519 ABDOMINAL DISCOMFORT 1641 0.0098
520 INABILITY TO AFFORD MEDICATION 97 0.0098
521 MUSCULOSKELETAL DISCOMFORT 168 0.0098
522 WRIST FRACTURE 117 0.0098
523 ERUCTATION 188 0.0097
524 SCAR 166 0.0097
525 INTENTIONAL DOSE OMISSION 276 0.0097
526 PETECHIAE 101 0.0097
527 BASAL CELL CARCINOMA 151 0.0097
528 VISION BLURRED 1327 0.0097
529 UPPER RESPIRATORY TRACT INFECTION 446 0.0096
530 HYPERTHYROIDISM 139 0.0096
531 NEUROPATHY PERIPHERAL 912 0.0096
532 ACTIVITIES OF DAILY LIVING IMPAIRED 189 0.0095
533 OBSTRUCTIVE AIRWAYS DISORDER 106 0.0095
534 RENAL PAIN 101 0.0095
535 LUNG DISORDER 466 0.0095
536 HYPERCALCAEMIA 117 0.0095
537 COLON CANCER 141 0.0095
538 HYPOACUSIS 407 0.0094
539 HYPERHIDROSIS 1215 0.0094
540 CHROMATURIA 212 0.0094
541 RHINORRHOEA 607 0.0094
542 HAEMORRHAGE 977 0.0093
543 PULMONARY ARTERIAL HYPERTENSION 135 0.0093
544 LOWER LIMB FRACTURE 179 0.0093
545 ADRENAL INSUFFICIENCY 113 0.0093
546 MUSCLE SPASMS 1707 0.0093
547 MEMORY IMPAIRMENT 1277 0.0093
548 WHEEZING 550 0.0093
549 PERITONITIS 192 0.0093
550 MYELODYSPLASTIC SYNDROME 134 0.0093
551 GASTROINTESTINAL INFECTION 83 0.0092
552 ILEUS 115 0.0092
553 MYOCLONUS 110 0.0092
554 WOUND INFECTION 101 0.0092
555 JOINT INJURY 197 0.0092
556 VERTIGO 562 0.0092
557 ARTHRITIS 724 0.0092
558 INTERVERTEBRAL DISC PROTRUSION 201 0.0092
559 DENTAL CARIES 101 0.0091
560 FOOT FRACTURE 173 0.0091
561 TACHYPNOEA 124 0.0091
562 SCAB 104 0.0091
563 SECRETION DISCHARGE 114 0.0091
564 SCRATCH 96 0.0091
565 APHONIA 127 0.0091
566 DYSPHAGIA 859 0.0090
567 SPEECH DISORDER 474 0.0090
568 SKIN LESION 248 0.0090
569 DEVICE RELATED INFECTION 139 0.0090
570 FEELING ABNORMAL 2159 0.0090
571 LACRIMATION INCREASED 272 0.0090
572 DRUG LEVEL INCREASED 149 0.0090
573 PRURITUS GENERALISED 194 0.0090
574 BLOOD CREATINE PHOSPHOKINASE INCREASED 258 0.0090
575 DYSGEUSIA 665 0.0089
576 PAIN IN JAW 253 0.0089
577 NEURALGIA 217 0.0089
578 HOT FLUSH 672 0.0089
579 AMNESIA 580 0.0089
580 WHITE BLOOD CELL COUNT DECREASED 964 0.0089
581 POOR QUALITY SLEEP 191 0.0089
582 MYALGIA 1506 0.0088
583 ABDOMINAL PAIN UPPER 1823 0.0088
584 BLOOD TEST ABNORMAL 124 0.0088
585 APHASIA 266 0.0088
586 PRODUCT DOSE OMISSION 575 0.0088
587 DEPRESSED LEVEL OF CONSCIOUSNESS 348 0.0088
588 DEAFNESS 230 0.0088
589 SPINAL PAIN 103 0.0088
590 PANCYTOPENIA 491 0.0088
591 HYPOAESTHESIA 1312 0.0088
592 NEPHROLITHIASIS 402 0.0088
593 ERECTILE DYSFUNCTION 225 0.0088
594 CIRCULATORY COLLAPSE 149 0.0087
595 ORAL CANDIDIASIS 115 0.0087
596 LOCAL SWELLING 152 0.0087
597 SQUAMOUS CELL CARCINOMA 82 0.0087
598 INFLUENZA 970 0.0087
599 BLISTER 488 0.0087
600 SPINAL OPERATION 107 0.0087
601 FEEDING DISORDER 176 0.0087
602 HALLUCINATION, VISUAL 183 0.0087
603 SOMNOLENCE 1744 0.0087
604 BODY TEMPERATURE DECREASED 85 0.0086
605 BACTERIAL INFECTION 161 0.0086
606 THROMBOCYTOPENIA 963 0.0086
607 GASTRIC DISORDER 295 0.0086
608 RETINAL DETACHMENT 79 0.0086
609 INSOMNIA 2288 0.0086
610 NAUSEA 6781 0.0086
611 DIARRHOEA HAEMORRHAGIC 80 0.0085
612 HEAD DISCOMFORT 151 0.0085
613 MASS 119 0.0085
614 GENERAL PHYSICAL HEALTH DETERIORATION 985 0.0085
615 JOINT RANGE OF MOTION DECREASED 114 0.0085
616 PANCREATITIS ACUTE 191 0.0085
617 VISUAL ACUITY REDUCED 281 0.0085
618 PNEUMOTHORAX 134 0.0084
619 ALTERED STATE OF CONSCIOUSNESS 183 0.0084
620 IMPAIRED DRIVING ABILITY 96 0.0084
621 NERVOUSNESS 441 0.0084
622 SWOLLEN TONGUE 263 0.0084
623 RASH PRURITIC 456 0.0084
624 TACHYCARDIA 746 0.0084
625 BONE DISORDER 153 0.0084
626 TOOTHACHE 152 0.0084
627 THERAPY CESSATION 431 0.0084
628 COVID-19 PNEUMONIA 99 0.0084
629 PARALYSIS 120 0.0084
630 INFUSION SITE PAIN 108 0.0084
631 OCULAR DISCOMFORT 94 0.0084
632 NASAL CONGESTION 492 0.0084
633 MULTIPLE ORGAN DYSFUNCTION SYNDROME 237 0.0084
634 OSTEOPOROSIS 344 0.0084
635 HALLUCINATION 628 0.0083
636 RESPIRATORY DISORDER 249 0.0083
637 ANXIETY 2365 0.0083
638 BLOOD ALKALINE PHOSPHATASE INCREASED 206 0.0083
639 BLOOD BILIRUBIN INCREASED 224 0.0083
640 PLATELET COUNT INCREASED 108 0.0083
641 RESPIRATORY TRACT INFECTION 215 0.0082
642 VOMITING 3865 0.0082
643 DEPRESSION 1867 0.0082
644 NODULE 107 0.0082
645 LIVER FUNCTION TEST ABNORMAL 237 0.0081
646 JOINT SWELLING 980 0.0081
647 PANCREATITIS 429 0.0081
648 INSURANCE ISSUE 124 0.0081
649 METASTASES TO BONE 133 0.0081
650 GASTROINTESTINAL PAIN 89 0.0081
651 GASTROENTERITIS VIRAL 146 0.0081
652 TOXICITY TO VARIOUS AGENTS 1363 0.0081
653 DEEP VEIN THROMBOSIS 524 0.0081
654 BURNING SENSATION 564 0.0080
655 ABDOMINAL PAIN 1871 0.0080
656 MOVEMENT DISORDER 258 0.0080
657 ULCER 127 0.0080
658 MALAISE 3494 0.0080
659 PARAESTHESIA 1253 0.0080
660 ACCIDENT 95 0.0079
661 TEMPERATURE INTOLERANCE 82 0.0079
662 JOINT DISLOCATION 84 0.0079
663 FULL BLOOD COUNT ABNORMAL 84 0.0079
664 COLITIS 301 0.0079
665 ANGIOEDEMA 351 0.0079
666 BEDRIDDEN 104 0.0079
667 PRODUCT AVAILABILITY ISSUE 180 0.0079
668 SWELLING FACE 512 0.0079
669 BLADDER DISORDER 78 0.0078
670 SKIN HAEMORRHAGE 116 0.0078
671 BONE PAIN 458 0.0078
672 WOUND 218 0.0078
673 GLAUCOMA 150 0.0078
674 LIVER DISORDER 345 0.0078
675 PHOTOPHOBIA 146 0.0078
676 NIGHT SWEATS 250 0.0078
677 ASPARTATE AMINOTRANSFERASE INCREASED 412 0.0077
678 TOOTH DISORDER 172 0.0077
679 LUNG INFECTION 120 0.0077
680 STOMATITIS 468 0.0077
681 MUSCLE TIGHTNESS 125 0.0077
682 THERAPY INTERRUPTED 549 0.0077
683 SLEEP DISORDER 542 0.0077
684 BRAIN INJURY 77 0.0077
685 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 546 0.0077
686 DISSEMINATED INTRAVASCULAR COAGULATION 108 0.0077
687 NEPHROPATHY TOXIC 86 0.0077
688 MIDDLE INSOMNIA 143 0.0076
689 VISUAL IMPAIRMENT 946 0.0076
690 LACTIC ACIDOSIS 247 0.0076
691 EYE INFECTION 86 0.0076
692 MYOCARDITIS 87 0.0076
693 MOBILITY DECREASED 545 0.0076
694 IMPAIRED QUALITY OF LIFE 109 0.0076
695 PRURITUS 2912 0.0076
696 ROAD TRAFFIC ACCIDENT 316 0.0075
697 VIRAL INFECTION 251 0.0075
698 MALIGNANT MELANOMA 101 0.0075
699 SNEEZING 169 0.0075
700 FEMUR FRACTURE 233 0.0075
701 CANDIDA INFECTION 127 0.0075
702 IMMUNODEFICIENCY 112 0.0075
703 IMPAIRED HEALING 246 0.0075
704 ORAL DISCOMFORT 104 0.0075
705 PHARMACEUTICAL PRODUCT COMPLAINT 194 0.0075
706 THERAPEUTIC RESPONSE UNEXPECTED 335 0.0075
707 SINUSITIS 765 0.0075
708 PRODUCT TASTE ABNORMAL 101 0.0075
709 FEELING JITTERY 142 0.0074
710 ARTHRALGIA 3096 0.0074
711 MEDICATION ERROR 412 0.0074
712 EYE DISCHARGE 77 0.0074
713 SKIN CANCER 159 0.0074
714 BRONCHOSPASM 105 0.0074
715 LYMPHOCYTE COUNT DECREASED 130 0.0073
716 ACUTE RESPIRATORY DISTRESS SYNDROME 130 0.0073
717 DELIRIUM 255 0.0073
718 PHARYNGEAL OEDEMA 113 0.0073
719 BLINDNESS 299 0.0073
720 PAIN 4504 0.0073
721 HERPES ZOSTER 421 0.0073
722 PRODUCT DOSE OMISSION IN ERROR 207 0.0073
723 EAR PAIN 142 0.0073
724 METASTASES TO LUNG 84 0.0073
725 HEPATIC FAILURE 219 0.0073
726 ILL-DEFINED DISORDER 441 0.0073
727 METASTASES TO LIVER 127 0.0072
728 BREAST PAIN 77 0.0072
729 LIP SWELLING 240 0.0072
730 THROAT IRRITATION 323 0.0072
731 INTESTINAL OBSTRUCTION 270 0.0072
732 ARTHROPATHY 397 0.0071
733 ALOPECIA 1402 0.0071
734 DRUG ADMINISTRATION ERROR 219 0.0071
735 ABNORMAL DREAMS 197 0.0071
736 HEADACHE 4451 0.0071
737 SURGERY 416 0.0071
738 CYST 88 0.0071
739 HOSPITALISATION 1087 0.0071
740 INCREASED APPETITE 135 0.0071
741 RASH MACULAR 246 0.0070
742 CHILLS 823 0.0070
743 INTENTIONAL OVERDOSE 447 0.0070
744 IRRITABLE BOWEL SYNDROME 149 0.0069
745 DISEASE PROGRESSION 821 0.0069
746 KNEE ARTHROPLASTY 146 0.0069
747 PULMONARY EMBOLISM 659 0.0069
748 INTENTIONAL PRODUCT MISUSE 607 0.0069
749 DRUG DOSE OMISSION 1144 0.0069
750 PRODUCT DOSE OMISSION ISSUE 2031 0.0069
751 OROPHARYNGEAL PAIN 639 0.0069
752 CONDITION AGGRAVATED 2098 0.0069
753 MUSCULOSKELETAL DISORDER 130 0.0068
754 COVID-19 1198 0.0068
755 EYE SWELLING 254 0.0068
756 DEATH 5882 0.0068
757 ATAXIA 81 0.0068
758 PRODUCT PHYSICAL ISSUE 137 0.0068
759 EYE DISORDER 223 0.0068
760 GAMMA-GLUTAMYLTRANSFERASE INCREASED 150 0.0068
761 ALANINE AMINOTRANSFERASE INCREASED 415 0.0068
762 BLOOD LACTATE DEHYDROGENASE INCREASED 107 0.0067
763 EMOTIONAL DISTRESS 816 0.0067
764 ILLNESS 694 0.0067
765 PRODUCT ADMINISTRATION ERROR 136 0.0067
766 NO THERAPEUTIC RESPONSE 82 0.0067
767 DYSKINESIA 273 0.0067
768 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 322 0.0067
769 DRUG-INDUCED LIVER INJURY 210 0.0067
770 JAUNDICE 180 0.0067
771 IMMUNE SYSTEM DISORDER 88 0.0067
772 TOOTH INFECTION 88 0.0067
773 CHOLECYSTECTOMY 76 0.0066
774 DRUG INTOLERANCE 641 0.0066
775 BRAIN FOG 104 0.0066
776 DELUSION 103 0.0066
777 FREQUENT BOWEL MOVEMENTS 179 0.0066
778 SKIN DISORDER 221 0.0066
779 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 154 0.0066
780 COORDINATION ABNORMAL 92 0.0066
781 TREMOR 1092 0.0066
782 RASH GENERALISED 170 0.0066
783 TINNITUS 301 0.0065
784 NASOPHARYNGITIS 1207 0.0065
785 THINKING ABNORMAL 122 0.0065
786 INFECTION 947 0.0065
787 HUNGER 91 0.0065
788 DRY EYE 324 0.0065
789 SENSORY DISTURBANCE 104 0.0065
790 TENDON RUPTURE 80 0.0065
791 PRODUCT SUBSTITUTION ISSUE 373 0.0065
792 PNEUMONITIS 176 0.0065
793 C-REACTIVE PROTEIN INCREASED 234 0.0064
794 THERAPY NON-RESPONDER 289 0.0064
795 PULMONARY FIBROSIS 123 0.0064
796 HIP ARTHROPLASTY 98 0.0064
797 HYPOAESTHESIA ORAL 96 0.0064
798 TOOTH EXTRACTION 79 0.0063
799 PYREXIA 2192 0.0063
800 DIPLOPIA 164 0.0063
801 CYTOPENIA 77 0.0063
802 ABDOMINAL PAIN LOWER 159 0.0063
803 FIBROMYALGIA 152 0.0062
804 WRONG TECHNIQUE IN DRUG USAGE PROCESS 227 0.0062
805 PARAESTHESIA ORAL 90 0.0062
806 INTERSTITIAL LUNG DISEASE 300 0.0062
807 FUNGAL INFECTION 203 0.0061
808 RASH 2650 0.0061
809 HEPATIC FUNCTION ABNORMAL 226 0.0060
810 EYE IRRITATION 348 0.0060
811 INTENTIONAL PRODUCT USE ISSUE 526 0.0060
812 ADVERSE DRUG REACTION 538 0.0060
813 THROAT TIGHTNESS 162 0.0060
814 MENTAL IMPAIRMENT 145 0.0060
815 DEPRESSED MOOD 316 0.0060
816 EAR INFECTION 158 0.0059
817 TRANSAMINASES INCREASED 132 0.0059
818 RESTLESSNESS 217 0.0059
819 TOXIC EPIDERMAL NECROLYSIS 90 0.0059
820 OCULAR HYPERAEMIA 281 0.0059
821 PSYCHOMOTOR HYPERACTIVITY 98 0.0059
822 DISCOMFORT 359 0.0059
823 PRODUCT USE ISSUE 1103 0.0059
824 BODY TEMPERATURE INCREASED 119 0.0058
825 ABSCESS 93 0.0058
826 DISTURBANCE IN ATTENTION 308 0.0057
827 LYMPHADENOPATHY 202 0.0057
828 INFLAMMATION 294 0.0057
829 APATHY 83 0.0057
830 JOINT STIFFNESS 149 0.0057
831 UNDERDOSE 414 0.0057
832 NIGHTMARE 196 0.0057
833 EOSINOPHILIA 99 0.0056
834 GASTROINTESTINAL DISORDER 506 0.0056
835 FACE OEDEMA 95 0.0056
836 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1131 0.0056
837 MUSCULOSKELETAL STIFFNESS 488 0.0056
838 GLOSSODYNIA 124 0.0055
839 ANAPHYLACTIC REACTION 306 0.0055
840 HALLUCINATION, AUDITORY 88 0.0055
841 ASTHMA 625 0.0055
842 PRODUCT USE COMPLAINT 87 0.0055
843 SEIZURE 637 0.0055
844 DERMATITIS 115 0.0055
845 COMA 261 0.0055
846 PRESCRIBED OVERDOSE 106 0.0055
847 SKIN FISSURES 107 0.0055
848 PRODUCT QUALITY ISSUE 742 0.0055
849 EMOTIONAL DISORDER 168 0.0054
850 OFF LABEL USE 4744 0.0054
851 PHOTOSENSITIVITY REACTION 89 0.0054
852 PROCEDURAL PAIN 149 0.0054
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 967 0.0054
854 HYPERSENSITIVITY 994 0.0053
855 HEPATIC ENZYME INCREASED 365 0.0053
856 ADVERSE EVENT 493 0.0053
857 ACUTE MYELOID LEUKAEMIA 83 0.0053
858 LIVER FUNCTION TEST INCREASED 113 0.0053
859 STEVENS-JOHNSON SYNDROME 117 0.0053
860 DISABILITY 104 0.0053
861 TOOTH LOSS 109 0.0053
862 MUSCLE TWITCHING 121 0.0052
863 DIABETIC KETOACIDOSIS 126 0.0052
864 AGITATION 385 0.0052
865 PANIC ATTACK 190 0.0052
866 IMPAIRED WORK ABILITY 111 0.0052
867 INFLUENZA LIKE ILLNESS 426 0.0052
868 SKIN EXFOLIATION 435 0.0052
869 BONE DENSITY DECREASED 160 0.0051
870 RASH ERYTHEMATOUS 244 0.0051
871 DRY SKIN 678 0.0051
872 CONJUNCTIVITIS 94 0.0051
873 DRUG EFFECT DECREASED 271 0.0050
874 ERYTHEMA 1032 0.0050
875 FRACTURE 95 0.0050
876 LUNG NEOPLASM MALIGNANT 206 0.0050
877 COGNITIVE DISORDER 234 0.0050
878 PSORIASIS 654 0.0050
879 PRODUCT DISPENSING ERROR 109 0.0050
880 HEPATITIS 127 0.0050
881 GENERALISED TONIC-CLONIC SEIZURE 82 0.0050
882 EXPIRED PRODUCT ADMINISTERED 164 0.0049
883 NEUTROPHIL COUNT DECREASED 201 0.0049
884 MUCOSAL INFLAMMATION 129 0.0049
885 CRYING 179 0.0049
886 LYMPHOMA 76 0.0049
887 FEBRILE NEUTROPENIA 326 0.0049
888 MALIGNANT NEOPLASM PROGRESSION 501 0.0049
889 PRODUCT USE IN UNAPPROVED INDICATION 1210 0.0049
890 DRUG EFFECT INCOMPLETE 177 0.0049
891 MULTIPLE FRACTURES 79 0.0048
892 NEUTROPENIA 652 0.0048
893 OSTEONECROSIS OF JAW 118 0.0048
894 INCORRECT DOSE ADMINISTERED 1085 0.0047
895 NEOPLASM PROGRESSION 165 0.0047
896 DRUG ERUPTION 84 0.0047
897 CONVULSION 271 0.0047
898 ANAPHYLACTIC SHOCK 122 0.0047
899 MENTAL DISORDER 202 0.0046
900 ABNORMAL BEHAVIOUR 183 0.0046
901 NERVOUS SYSTEM DISORDER 144 0.0046
902 INTENTIONAL DRUG MISUSE 95 0.0045
903 HEPATOTOXICITY 101 0.0045
904 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 248 0.0045
905 DRUG INEFFECTIVE 5941 0.0045
906 RASH PAPULAR 101 0.0045
907 THERAPEUTIC RESPONSE DECREASED 273 0.0045
908 RASH MACULO-PAPULAR 100 0.0045
909 MOUTH ULCERATION 94 0.0045
910 PRODUCT PRESCRIBING ISSUE 97 0.0044
911 OVERDOSE 959 0.0044
912 EYE PRURITUS 149 0.0044
913 NEOPLASM MALIGNANT 295 0.0044
914 IRRITABILITY 265 0.0044
915 LEUKOPENIA 219 0.0044
916 MOOD ALTERED 119 0.0044
917 PSORIATIC ARTHROPATHY 177 0.0044
918 AGRANULOCYTOSIS 81 0.0044
919 INCORRECT DRUG ADMINISTRATION DURATION 122 0.0043
920 NEUROTOXICITY 76 0.0043
921 DISEASE RECURRENCE 205 0.0043
922 AGGRESSION 214 0.0043
923 URTICARIA 714 0.0043
924 DEVICE MALFUNCTION 298 0.0042
925 APPLICATION SITE PRURITUS 96 0.0042
926 INFUSION RELATED REACTION 277 0.0042
927 ACCIDENTAL OVERDOSE 152 0.0042
928 PAIN OF SKIN 109 0.0040
929 CHOLESTASIS 77 0.0040
930 ANGER 135 0.0040
931 INJECTION SITE MASS 147 0.0040
932 CYTOKINE RELEASE SYNDROME 78 0.0039
933 APPLICATION SITE PAIN 84 0.0038
934 SEDATION 99 0.0038
935 LIVER INJURY 91 0.0037
936 MIGRAINE 349 0.0037
937 WITHDRAWAL SYNDROME 151 0.0036
938 PSYCHOTIC DISORDER 104 0.0035
939 INJECTION SITE BRUISING 280 0.0035
940 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 88 0.0034
941 SUICIDE ATTEMPT 207 0.0034
942 THERAPEUTIC RESPONSE SHORTENED 113 0.0034
943 ECZEMA 178 0.0034
944 RHEUMATOID ARTHRITIS 382 0.0034
945 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 238 0.0033
946 EXTRA DOSE ADMINISTERED 132 0.0033
947 SYSTEMIC LUPUS ERYTHEMATOSUS 114 0.0032
948 INJECTION SITE HAEMORRHAGE 256 0.0032
949 GASTRIC CANCER 80 0.0032
950 NO ADVERSE EVENT 572 0.0032
951 DEVICE ISSUE 275 0.0031
952 VAGINAL HAEMORRHAGE 133 0.0031
953 NEEDLE ISSUE 85 0.0029
954 MOOD SWINGS 93 0.0029
955 GYNAECOMASTIA 90 0.0029
956 THERAPEUTIC PRODUCT EFFECT DECREASED 129 0.0029
957 PANCREATIC CARCINOMA 82 0.0028
958 INJECTION SITE PAIN 861 0.0028
959 SKIN BURNING SENSATION 201 0.0028
960 PREMATURE BABY 84 0.0028
961 MULTIPLE SCLEROSIS RELAPSE 191 0.0028
962 PRODUCT ADHESION ISSUE 94 0.0026
963 OSTEONECROSIS 86 0.0026
964 COLITIS ULCERATIVE 117 0.0026
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 88 0.0026
966 INJECTION SITE PRURITUS 174 0.0026
967 INCORRECT ROUTE OF DRUG ADMINISTRATION 92 0.0026
968 SUICIDAL IDEATION 232 0.0025
969 SKIN IRRITATION 116 0.0025
970 EPILEPSY 77 0.0025
971 DERMATITIS ATOPIC 131 0.0025
972 MULTIPLE SCLEROSIS 116 0.0024
973 LOWER RESPIRATORY TRACT INFECTION 107 0.0024
974 PROSTATE CANCER 189 0.0023
975 BREAST CANCER 217 0.0023
976 ACNE 168 0.0022
977 DEVICE LEAKAGE 95 0.0022
978 INJECTION SITE ERYTHEMA 268 0.0022
979 INJECTION SITE SWELLING 161 0.0021
980 INJECTION SITE REACTION 132 0.0019
981 RENAL CANCER 90 0.0019
982 EXPOSURE DURING PREGNANCY 114 0.0018
983 DEVICE DISLOCATION 79 0.0018
984 ACCIDENTAL EXPOSURE TO PRODUCT 183 0.0018
985 PRODUCT STORAGE ERROR 137 0.0016
986 BLADDER CANCER 89 0.0015
987 TREATMENT FAILURE 123 0.0015
988 DRUG WITHDRAWAL SYNDROME 126 0.0014
989 DRUG ABUSE 114 0.0014
990 FOETAL EXPOSURE DURING PREGNANCY 104 0.0013
991 MATERNAL EXPOSURE DURING PREGNANCY 111 0.0012
992 DRUG DOSE OMISSION BY DEVICE 96 0.0012
993 DEVICE DIFFICULT TO USE 79 0.0012
994 DRUG DEPENDENCE 99 0.0006